The vitamin D paradox: Bone density testing in females aged 45 to 74 did not increase over a ten-year period despite a marked increase in testing for vitamin D

Journal of Endocrinological Investigation

Volumn 36, Issue 11, 2013, Pages 914-922

  Boyages, S ^a   Bilinski, K ^b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

25 Hydroxyvitamin D; Bone densitometry; Health care utilisation; Osteoporosis; Vitamin D deficiency

Indexed keywords

VITAMIN D;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; BONE DENSITOMETRY; COST BENEFIT ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICARE; MIDDLE AGED; OSTEOPOROSIS;

ABSORPTIOMETRY, PHOTON; AGED; AUSTRALIA; BLOOD CELL COUNT; BONE DENSITY; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; OSTEOPOROSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84880446351     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8922     Document Type: Article

References (19)

1. Kanis J. WHO Technical Report, University of Sheffield, UK, 2007.
2. Sambrook PN, Seeman E, Phillips SR, et al. Preventing osteoporosis: outcomes of the Australian Fracture Prevention Summit. Med J Aust 2002, 176 (Suppl): S1-16.
3. International Osteoporosis Foundation [Internet]. [Accessed 22 June 2012] Available at: http://www.iofbonehealth.org/bonehealth/
4. Berger C, Joseph L, Hanley DA, et al. Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. Can Med Assoc J 2008, 178: 1660-8.
5. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995, 332: 767-73.
6. Kota SK, Kota SK, Krishna SVS, Meher LK, Modi KD. Relation of vitamin D levels with bone mineral density and parathyroid hormone in adults with low bone density. Endocr Rev 2012, 33: (03 Meeting Abstracts) SAT-359.
7. Rajakumar K. Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective. Pediatrics 2003, 112: e132-5.
8. Holick MF. Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging 2007, 24: 1017-29.
9. Bischoff-Ferrari HA, Willett WC, Orav EJ, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012, 367: 40-9.
10. Holick MF. Vitamin D deficiency. N Engl J Med 2007, 357: 266-81.
11. Bilinski K, Boyages S. The rising cost of vitamin D testing in Australia: Time to establish guidelines for testing. Med J Aust 2012, 197: 90.
12. Bilinski K, Boyages S. Preventing overdiagnosis: the rise and rise of Vitamin D testing. BMJ 2012, 345: e4743.
13. MBS Online. Medicare Benefits Schedule, ed. July 2011, Australian Government. Department of Health and Aging, 2011.
14. Rosen CJ, Adams JS, Bikle DD, et al. The Nonskeletal Effects of Vitamin D: An Endocrine Society Scientific Statement. Endocr Rev 2012, 33: 456-92.
15. Boyages S, Bilinski K. Seasonal reduction in vitamin D level persists into spring in NSW Australia: implications for monitoring and replacement therapy. Clin Endocrinol (Oxf) 2012, 77: 515-23.
16. Lewiecki EM. Update on bone density testing. Curr Osteoporos Rep 2005, 3: 136-42.
17. Lewiecki EM, Laster AJ, Miller PD, et al. More bone density testing is needed, not less. J Bone Miner Res 2012, 27: 739-42.
18. Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men. South Melbourne, Victoria: The Royal Australian College of General Practitioners, 2010.
19. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ 2012, 344: e3502.